Related Experiment Video
Updated: Feb 24, 2026
Author Spotlight: Enhancing Coronary Artery Revascularization
Published on: September 15, 2023
A Comparison of Inflammatory Responses Between Robotically Enhanced Coronary Artery Bypass Grafting and Conventional
Galina Leyvi1, Kumar Vivek1, Sankalp Sehgal1
1Department of Anesthesia, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY.
Insights
Robotically enhanced coronary artery bypass grafting (r-CABG) shows a reduced inflammatory response compared to conventional CABG. Further research is needed to understand the implications of C-reactive protein (CRP) levels post-r-CABG for hybrid procedures.
Area of Science:
- Cardiovascular Surgery
- Inflammatory Response
- Minimally Invasive Techniques
Background:
- The inflammatory response to robotically enhanced coronary artery bypass grafting (r-CABG) is not well understood.
- This inflammatory milieu may impact stent patency in hybrid coronary revascularization.
Purpose of the Study:
- To compare the extent and time course of cytokine release after r-CABG versus conventional CABG (c-CABG).
- To inform optimal timing for r-CABG in hybrid procedures.
Main Methods:
- Prospective observational study at a tertiary-care university hospital.
- Measured cytokine levels (IL-6, IL-8, IL-10, TNF-α) and CRP pre-procedure and up to 48 hours post-procedure.
- Compared 28 r-CABG patients with 10 c-CABG patients using mixed-effect linear regression.
Main Results:
- r-CABG demonstrated a blunted inflammatory response with lower IL-6, IL-10, TNF-α, and CRP levels compared to c-CABG.
- Most cytokine levels returned to baseline by 48 hours post-procedure in both groups.
- C-reactive protein (CRP) levels peaked at 48 hours post-procedure in both groups.
Conclusions:
- The inflammatory response to r-CABG is less pronounced than with c-CABG.
- Elevated postoperative CRP levels after r-CABG warrant further investigation regarding percutaneous coronary intervention timing.
Objective:
The inflammatory response elicited by robotically enhanced coronary artery bypass grafting (r-CABG) has not been well described. When r-CABG is performed as part of hybrid coronary revascularization, the inflammatory milieu and the timing of percutaneous coronary intervention may affect the stent patency negatively in the short and long term. The goal of this study was to describe the extent and time course of cytokine release after r-CABG compared with conventional CABG (c-CABG) and to elucidate the optimal timing for r-CABG in the setting of hybrid coronary revascularization for a future study.
Design:
Prospective, observational study.
Setting:
Tertiary-care center in a university hospital.
Participants:
The study comprised patients scheduled to undergo r-CABG or c-CABG from October 2012 to November 2014.
Interventions:
Cytokine levels of interleukin (IL)-6, IL-8, IL-10; tumor necrosis factor-α; and C-reactive protein (CRP) were measured at the following time points: preprocedure; at the end of the procedure; and at 4, 8, 12, 24, and 48 hours after the procedure.
Measurements And Main Results:
Twenty-eight patients undergoing r-CABG and 10 patients undergoing c-CABG were enrolled. The levels of cytokines after r-CABG and c-CABG were compared using the mixed-effect linear regression model for longitudinal data. Cytokine release in the r-CABG group was comparatively less for IL-6, IL-10, tumor necrosis factor, and CRP levels. They all trended toward the baseline by the 48th hour in both groups, except CRP levels, which reached their peak at 48 hours in both groups.
Conclusions:
The inflammatory response to r-CABG was blunted compared with that of c-CABG. The high CRP levels on the second postoperative day after r-CABG were a cause for concern in regard to percutaneous coronary intervention performed at that time period, but additional studies are necessary.
